000			02981nam a22002778i 4500
999			_c33972 _d33972
008			190819s2019 nyu b 000|0|eng|d
020			_a9780190654818 (pbk.) : _c£32.99
040			_aStDuBDS
060			_aWM 402.
100	1		_aGupta, Swapnil
245	1	0	_aDeprescribing in psychiatry
264		1	_aNew York : _bOxford University Press, _c2019.
300			_a xiv, 247 pages ; _c24 cm
504			_aIncludes bibliographical references.
505			_aPreface p. ix Acknowledgments p. xiii I The Context for Deprescribing 1 Deprescribing in Psychiatry: An Introduction p. 3 2 Decision-Making in Deprescribing p. 23 3 Barriers to Deprescribing: Origins and Solutions p. 47 4 Nonpharmacological Aspects of Deprescribing p. 69 II The Intervention of Deprescribing 5 Wellness Approaches I: Self-Determined Strategies p. 87 6 Wellness Approaches II: Collaborative Strategies p. 103 7 The Process of Deprescribing p. 119 8 Deprescribing Antidepressant Medications in Major Depressive Disorder p. 137 9 Deprescribing Antipsychotic Medications p. 159 10 Deprescribing Mood Stabilizers p. 185 11 Deprescribing Benzodiazepines, Z-Drugs, and Stimulants p. 199 12 Concluding Thoughts and Future Directions p. 217 Appendix p. 229 Index p. 235
520			_aThe current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term "deprescribing" refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits. Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour. As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.
650		0	_aMental disorders
650		0	_aPsychotropic drugs _97615
650		0	_aPrescriptions, drug
650		0	_aDrug therapy
650		0	_aPsychopharmacology
650		0	_aAdverse effects
700	1		_aMiller, Rebecca
700	1		_aCahill, John
942			_n0